Figures computed from official regulatory filings — .
Analysttarget 152.5 USD (+112%) · consensus 5/5 · 3 buy · 0 hold · 0 sell
Ownershipinsiders 59.66% · institutions 43.05% · short 11.6% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Sol-Gel Technologies Ltd. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel, China, Switzerland, Canada, the United States and internationally. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea. It also develops SGT-610 that is in Phase 3 clinical trials for the treatment of Gorlin Syndrome; and SGT-210, which has completed Phase I clinical trial, to treat olmsted syndrome. It has collaboration with Padagis Israel Pharmaceuticals Ltd; and license agreements with Galderma Holding SA and Searchlight Pharma Inc. Sol-Gel Technologies Ltd. was incorporated in 1997 and is headquartered in Ness Ziona, Israel.
Market information source · Oct 5, 2026
SEC company identity · Oct 5, 2026
Open-market timeline · full history
49 buys— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| Opaleye Management Inc.track record | Buy | $98.5K | conv 25 |
| Opaleye Management Inc.track record | Buy | $108.9K | conv 25 | SEC |
| Opaleye Management Inc.track record | Buy | $144.9K | conv 24 | SEC |
| Opaleye Management Inc.track record | Buy | $63.8K | conv 24 | SEC |
| Opaleye Management Inc.track record | Buy | $212.8K | conv 24 | SEC |
| Opaleye Management Inc.track record | Buy | $32.7K | conv 24 | SEC |
| Opaleye Management Inc.track record | Buy | $233K | conv 24 | SEC |
| Opaleye Management Inc.track record | Buy | $62.1K | conv 24 | SEC |
| Opaleye Management Inc.track record | Buy | $54.4K | conv 24 | SEC |
| Opaleye Management Inc.track record | Buy | $714K | conv 39 | SEC |
| Opaleye Management Inc.track record | Buy | $344.1K | conv 29 | SEC |
| Opaleye Management Inc.track record | Buy | $341.2K | conv 25 | SEC |
| Opaleye Management Inc.track record | Buy | $15K | conv 24 | SEC |
| Opaleye Management Inc.track record | Buy | $1.4M | conv 49Unusual size | SEC |
| Opaleye Management Inc.track record | Buy | $68K | conv 17 | SEC |
| Opaleye Management Inc.track record | Buy | $67.6K | conv 23 | SEC |
| Opaleye Management Inc.track record | Buy | $57.3K | conv 23 | SEC |
| Opaleye Management Inc.track record | Buy | $16.9K | conv 23 | SEC |
| Opaleye Management Inc.track record | Buy | $22.1K | conv 17 | SEC |
| Opaleye Management Inc.track record | Buy | $100.8K | conv 23 | SEC |
| Opaleye Management Inc.track record | Buy | $22.5K | conv 23 | SEC |
| Opaleye Management Inc.track record | Buy | $100.7K | conv 25 | SEC |
| Opaleye Management Inc.track record | Buy | $129.5K | conv 23 | SEC |
| Opaleye Management Inc.track record | Buy | $102K | conv 18 | SEC |
| Opaleye Management Inc.track record | Buy | $2.5M | conv 32Unusual size | SEC |